Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Cellular Immunology|October 6, 2015
Tolerance and immune suppression in the tumor microenvironmentSuzanne Ostrand-RosenbergCancer Immunology, Immunotherapy : CII|April 24, 2010
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunitySuzanne Ostrand-RosenbergCurrent Opinion in Genetics & Development|March 1, 2008
Immune surveillance: a balance between protumor and antitumor immunitySuzanne Ostrand-RosenbergCurrent Opinion in Immunology|March 17, 2004
Animal models of tumor immunity, immunotherapy and cancer vaccinesSuzanne Ostrand-RosenbergCurrent Opinion in Immunology|March 16, 2018
Myeloid derived-suppressor cells: their role in cancer and obesitySuzanne Ostrand-RosenbergCancer Investigation|October 1, 2005
CD4+ T lymphocytes: a critical component of antitumor immunitySuzanne Ostrand-RosenbergJournal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Myeloid-derived suppressor cells: linking inflammation and cancerSuzanne Ostrand-Rosenberg, Pratima SinhaCancer Immunology, Immunotherapy : CII|January 20, 2004
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chainDan Ilkovitch, Suzanne Ostrand-RosenbergCancer Immunology, Immunotherapy : CII|August 29, 2013
Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extractPratima Sinha, Suzanne Ostrand-RosenbergJournal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their EnvironmentSuzanne Ostrand-Rosenberg, Catherine FenselauPageof 9